相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor plus breast cancer
Amy R. Dwyer et al.
BRITISH JOURNAL OF CANCER (2021)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
Pingping Mao et al.
CLINICAL CANCER RESEARCH (2020)
Isoform- and Paralog-Switching in IR-Signaling: When Diabetes Opens the Gates to Cancer
Pierluigi Scalia et al.
BIOMOLECULES (2020)
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
Veronica Vella et al.
CELLS (2019)
Insulin Receptor Isoforms in Cancer
Veronica Vella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2017)
Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds
Jie Ying Chan et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients
Raul M. Luque et al.
ONCOTARGET (2017)
The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications
O. Escribano et al.
JOURNAL OF DIABETES RESEARCH (2017)
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
Pedro M. Aponte et al.
STEM CELLS INTERNATIONAL (2017)
Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation
Dedra H. Fagan et al.
HORMONES & CANCER (2017)
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
William J. Gradishar et al.
CLINICAL CANCER RESEARCH (2016)
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
Zara Zelenko et al.
ENDOCRINE-RELATED CANCER (2016)
Development of a Quantitative PCR Assay for Detection of Human Insulin-Like Growth Factor Receptor and Insulin Receptor Isoforms
Clare A. Flannery et al.
ENDOCRINOLOGY (2016)
Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
J. Y. Chan et al.
ONCOGENE (2016)
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M. Anderson et al.
PEDIATRIC BLOOD & CANCER (2016)
Highly specific role of the insulin receptor in breast cancer progression
Ran Rostoker et al.
ENDOCRINE-RELATED CANCER (2015)
Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
Hongxin Cao et al.
PLOS ONE (2015)
Engineered ubiquitin ligase PTB-U-box targets insulin/insulin-like growth factor receptor for degradation and coordinately inhibits cancer malignancy
Qinhao Wang et al.
ONCOTARGET (2014)
Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation
James P. Dean et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
John F. R. Robertson et al.
LANCET ONCOLOGY (2013)
Quantifying insulin receptor isoform expression in FFPE breast tumors
Sean C. Harrington et al.
GROWTH HORMONE & IGF RESEARCH (2012)
A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
Emily M. Fox et al.
CANCER RESEARCH (2011)
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid
Roberta Malaguarnera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer
Todd W. Miller et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
H. Zhang et al.
ONCOGENE (2010)
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
Danielle B. Ulanet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Moller et al.
ENDOCRINE REVIEWS (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
IGF Ligand and Receptor Regulation of Mammary Development
Anne M. Rowzee et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Phase I dose escalation study of the anti-insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors
Paul Haluska et al.
CLINICAL CANCER RESEARCH (2007)
Insulin receptor activation in solitary fibrous tumours
Y. Li et al.
JOURNAL OF PATHOLOGY (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A
L Sciacca et al.
ONCOGENE (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
